| Company Name: | Palatin Technologies, Inc. | | Ticker Symbol: | PTN | | | WWW Address: | www.palatin.com | | CEO: | Dr. Carl Spana, Ph.D. | | No. of Employees: | 43 | | Common Issue Type: | CS | | Business Description: | A biopharmaceutical company, engaged in the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems.
|
| | | Industry Information: | DRUGS - Diagnostic Support [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.28 |  0.005 | 0.0001 | 0.3039 | 0.271 | 0.28 | 0.27 | 285481 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 26.9 | 96.2 | 1.47 | -0.06 | 0.00 | 0.0 | 0.0 | 0.48 - 0.06 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.28 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 26.9 | mil |
| Latest Shares Outstanding | 96.2 | mil |
| Earnings pS (EPS) | -0.06 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 264,000 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 92.5 | mil |
| Float as % of Shares Outstanding | 96.2 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 35.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 86.70 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | -12.3 | % |
| Pre-Tax Profit Margin | -16.1 | % |
| Assets Turnover | 1.0 | % |
| Return on Assets (ROA) | -3.6 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -8.6 | % |
| Current Ratio | 1.4 | |
| Leverage Ratio (Assets/Equity) | 2.4 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.01 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 0.04 | $ |
| Cash pS | 0.04 | $ |
| Book-Value pS | 0.07 | $ |
| Tangible Book-Value pS | 0.07 | $ |
| Cash Flow pS | 0.01 | $ |
| Free Cash Flow pS | -0.04 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 4.20 | |
| Price/Tangible Book Ratio | 4.20 | |
| Price/Cash Flow | 34.3 | |
| Price/Free Cash Flow | -6.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -15.2 | 85 | 3,531 | 22,317 |
| 4 Weeks | 0.37 | 0.27 | 0.35 | -20.0 | 79 | 3,751 | 75,010 |
| 13 Weeks | 0.44 | 0.27 | 0.32 | -12.6 | 82 | 9,179 | 587,431 |
| 26 Weeks | 0.48 | 0.20 | 0.26 | 7.7 | 88 | 7,446 | 945,702 |
| 52 Weeks | 0.48 | 0.06 | 0.06 | 358.3 | 336 | 6,201 | 1,556,457 |
| YTD | 0.48 | 0.06 | - | 211.5 | 258 | 6,091 | 1,370,376 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.29 | 0.29 | 0.33 | 0.29 | 0.24 | 1.47 | 1.08 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 4.86 | 3.8 | -11.77 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -29.75 | NA | -65.22 |
| R&D | -11.73 | NA | -31.35 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 385.9 | 385.9 | -1.1 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.05 | 0.05 | 0.11 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 1.13 |
| Current Ratio | 1.0 |
| Quick Ratio (Acid Test) | 1.0 |
| Liquidity Ratio (Cash) | 0.90 |
| Receivables Turnover | 44.1 |
| Average Collection Period | 8 |
| Working Capital/Equity | 4.5 |
| Working Capital pS | 0.00 |
| Cash-Flow pS | -0.04 |
| Free Cash-Flow pS | -0.06 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 0.41 |
| Financial Leverage Ratio (Assets/Equity) | 4.0 |
| Debt Ratio | 74.9 |
| Total Debt/Equity (Gearing Ratio) | 0.04 |
| LT Debt/Equity | 0.01 |
| LT Debt/Capital Invested | 36.3 |
| LT Debt/Total Liabilities | 0.3 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.57 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 5.24 |
| Tobin's Q Ratio | 2.04 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -4.88 |
| Enterprise Value (EV)/Free Cash Flow | -5.56 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 4.20 |
| Price/Book Ratio - LTM | 4.20 |
| Price/Cash Flow Ratio | 34.3 |
| Price/Free Cash Flow Ratio - LTM | -6.9 |
| Price/Sales Ratio | 1.89 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.10 |
| Tangible Book Value pS - LTM | 0.07 |
| Book Value pS - LTM | 0.07 |
| Capital Invested pS | 0.03 |
| Cash pS - LTM | 0.04 |
| Cash Flow pS - LTM | 0.01 |
| Free Cash Flow pS - LTM | -0.04 |
| Earnings pS (EPS) | -0.06 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -48.27 |
| Free Cash Flow Margin 5YEAR AVG | -109.06 |
| Net Profit Margin | -42.3 |
| Net Profit Margin - 5YEAR AVRG. | 0.0 |
| Equity Productivity | 3.43 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 3.39 |
| Return on Capital Invested (ROCI) | -143.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -159.5 |
| Assets Productivity | 0.70 |
| Return on Assets (ROA) | -36.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | -60.0 |
| Gross Profit Margin | 0.0 |
| Gross Profit Margin - 5YEAR AVRG. | 0.0 |
| EBITDA Margin - LTM | -12.3 |
| EBIT Margin - LTM | -15.9 |
| Pre-Tax Profit Margin | -57.6 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.0 |
| Effective Tax Rate | 26.6 |
| Effective Tax Rate - 5YEAR AVRG. | 8.7 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 16 |
| Revenue per Employee | 264,000 |
| Net Income per Employee | -111,674 |
| Average Collection Period | 16 |
| Receivables Turnover | 44.1 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 1.81 |
| Assets/Revenue | 1.43 |
| Net Working Capital Turnover | 76.19 |
| Fixed Assets Turnover | 2.59 |
| Total Assets Turnover | 0.7 |
| Revenue per $ Cash | 2.59 |
| Revenue per $ Plant | 3.11 |
| Revenue per $ Common Equity | 3.43 |
| Revenue per $ Capital Invested | 3.39 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 46.7 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 45.1 |
| Research & Devlopment (R&D) as % of Revenue | 117.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 117.7 |
|
|  
|
| |
 |  |